77 related articles for article (PubMed ID: 2116812)
1. Neisseria meningitidis group B capsular polysaccharide. Bacterial content and release in relation to categories of infection and filtrability of released endotoxin.
Hoddevik GM; Baastad KL; Bukholm G; Bryn K; Bøvre K
APMIS; 1990 Jun; 98(6):521-8. PubMed ID: 2116812
[TBL] [Abstract][Full Text] [Related]
2. Gas-chromatographic screening of capsular polysaccharides of Neisseria meningitidis.
Bryn K; Frøholm LO; Holten E; Bøvre K
NIPH Ann; 1983 Jun; 6(1):91-101. PubMed ID: 6413908
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin liberation from Neisseria meningitidis isolated from carriers and clinical cases.
Andersen BM; Solberg O; Bryn K; Frøholm LO; Gaustad P; Høiby EA; Kristiansen BE; Bøvre K
Scand J Infect Dis; 1987; 19(4):409-19. PubMed ID: 3118451
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin liberation associated with growth, encapsulation and virulence of Neisseria meningitidis.
Andersen BM; Solberg O
Scand J Infect Dis; 1988; 20(1):21-31. PubMed ID: 3129779
[TBL] [Abstract][Full Text] [Related]
5. Surface polysaccharide of Moraxella non-liquefaciens identical to Neisseria meningitidis group B capsular polysaccharide. A chemical and immunological investigation.
Bøvre K; Bryn K; Closs O; Hagen N; Frøholm LO
NIPH Ann; 1983 Jun; 6(1):65-73. PubMed ID: 6413906
[TBL] [Abstract][Full Text] [Related]
6. Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14.
Kocabas C; Katsenelson N; Kanswal S; Kennedy MN; Cui X; Blake MS; Segal DM; Akkoyunlu M
Cell Microbiol; 2007 May; 9(5):1297-310. PubMed ID: 17250593
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide structure and serum sensitivity of non-serogroupable Neisseria meningitidis.
Blackwell CC; Winstanley FP; Weir DM; Kinane DF
J Clin Lab Immunol; 1987 Sep; 24(1):29-32. PubMed ID: 3119854
[TBL] [Abstract][Full Text] [Related]
8. Bacteriocins in Neisseria meningitidis. Screening of systemic patient strains and pharyngeal isolates from healthy carriers.
Allunans J; Bøvre K
APMIS; 1996 Mar; 104(3):206-12. PubMed ID: 8611195
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin release from neisseria meningitidis. Relationship between key bacterial characteristics and meningococcal disease.
Andersen BM
Scand J Infect Dis Suppl; 1989; 64():1-43. PubMed ID: 2515592
[TBL] [Abstract][Full Text] [Related]
10. Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant.
Bjerre A; Brusletto B; Mollnes TE; Fritzsønn E; Rosenqvist E; Wedege E; Namork E; Kierulf P; Brandtzaeg P
J Infect Dis; 2002 Jan; 185(2):220-8. PubMed ID: 11807696
[TBL] [Abstract][Full Text] [Related]
11. The panmictic nature of Neisseria meningitidis serogroup B during a period of endemic disease in Canada.
Ashton FE; Caugant DA
Can J Microbiol; 2001 Apr; 47(4):283-9. PubMed ID: 11358166
[TBL] [Abstract][Full Text] [Related]
12. Genetic basis for nongroupable Neisseria meningitidis.
Dolan-Livengood JM; Miller YK; Martin LE; Urwin R; Stephens DS
J Infect Dis; 2003 May; 187(10):1616-28. PubMed ID: 12721942
[TBL] [Abstract][Full Text] [Related]
13. Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response.
Sprong T; Stikkelbroeck N; van der Ley P; Steeghs L; van Alphen L; Klein N; Netea MG; van der Meer JW; van Deuren M
J Leukoc Biol; 2001 Aug; 70(2):283-8. PubMed ID: 11493621
[TBL] [Abstract][Full Text] [Related]
14. Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis.
Brandt BL; Pier GB; Goroff DK; Altieri PL; Griffiss JM
J Gen Microbiol; 1980 May; 118(1):39-43. PubMed ID: 6775049
[TBL] [Abstract][Full Text] [Related]
15. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
16. Immunochemical studies and genetic background of two Neisseria meningitidis isolates expressing unusual capsule polysaccharide antigens with specificities of both serogroup Y and W135.
Tsang RS; Tsai CM; Henderson AM; Tyler S; Law DK; Zollinger W; Jamieson F
Can J Microbiol; 2008 Mar; 54(3):229-34. PubMed ID: 18388994
[TBL] [Abstract][Full Text] [Related]
17. Seroepidemiologic aspects of Neisseria meningitidis in homosexual men.
Salit IE; Frasch CE
Can Med Assoc J; 1982 Jan; 126(1):38-41. PubMed ID: 6800626
[TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
Krizova P; Musilek M
Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
[TBL] [Abstract][Full Text] [Related]
19. Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide.
Bjerre A; Brusletto B; Rosenqvist E; Namork E; Kierulf P; Øvstebø R; Joø GB; Brandtzaeg P
J Endotoxin Res; 2000; 6(6):437-45. PubMed ID: 11521068
[TBL] [Abstract][Full Text] [Related]
20. Chemokine patterns in meningococcal disease.
Møller AS; Bjerre A; Brusletto B; Joø GB; Brandtzaeg P; Kierulf P
J Infect Dis; 2005 Mar; 191(5):768-75. PubMed ID: 15688294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
